Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

SOCS1 in cancer: An oncogene and a tumor suppressor.

Beaurivage C, Champagne A, Tobelaim WS, Pomerleau V, Menendez A, Saucier C.

Cytokine. 2016 Jun;82:87-94. doi: 10.1016/j.cyto.2016.01.005.

PMID:
26811119
2.

Tumour-promoting role of SOCS1 in colorectal cancer cells.

Tobelaim WS, Beaurivage C, Champagne A, Pomerleau V, Simoneau A, Chababi W, Yeganeh M, Thibault P, Klinck R, Carrier JC, Ferbeyre G, Ilangumaran S, Saucier C.

Sci Rep. 2015 Sep 22;5:14301. doi: 10.1038/srep14301.

3.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators., Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858.

4.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators., Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859.

Supplemental Content

Loading ...
Support Center